RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CELESIA BM
Collezione ASL Città di Torino

Items : 33

Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study. in Viruses / Viruses. 2024 Apr 15;16(4):613. doi: 10.3390/v16040613.

2024
AOU Alessandria
ASL Città di Torino

Guadagnino G; Martini S; Ferrara S; Falasca K; Carleo MA; Bandera A; Cenderello G; Maggi P; Calza L; Sarchi E; Gulminetti R; Cascio A; Celesia BM; Bellagamba R; Pontali E; Salomoni E; Pellicanò GF; Madeddu G; Molteni C; De Socio GV; Di Biagio A; Taramasso L; Lagi F; Guastavigna M; Orofino G; Menzaghi B; Corti N; Angioni G; Bargiacchi O; et alii...

Pillars of long-term antiretroviral therapy success. in Pharmacological research / Pharmacol Res. 2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28.

2023
ASL Città di Torino

Taramasso L; Andreoni M; Antinori A; Bandera A; Bonfanti P; Bonora S; Borderi M; Castagna A; Cattelan AM; Celesia BM; Cicalini S; Cingolani A; Cossarizza A; D'Arminio Monforte A; D'Ettorre G; Di Biagio A; Di Giambenedetto S; Di Perri G; Esposito V; Focà E; Gervasoni C; Gori A; Gianotti N; Guaraldi G; Gulminetti R; Lo Caputo S; Madeddu G; Maggi P; Marandola G; et alii...

Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study. in Viruses / Viruses. 2023 Mar 10;15(3):720. doi: 10.3390/v15030720.

2023
AOU Alessandria
ASL Città di Torino

Di Biagio A; Falasca K; Cenderello G; Cascio A; Sarchi E; Pellicanò GF; Parruti G; Celesia BM; Costa C; Valsecchi L; Molteni C; De Socio GV; Squillace N; Taramasso L; Orofino G; Martinelli CV; Ricci E; Menzaghi B; De Vito A; Bonfanti P; Madeddu G;

Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting. in Viruses / Viruses. 2023 Jul 23;15(7):1612. doi: 10.3390/v15071612.

2023
AOU Alessandria
ASL Città di Torino

Bargiacchi O; Martini S; Sarchi E; Rusconi S; Calza L; Valsecchi L; Taramasso L; Parisini A; Carleo MA; Cascio A; Pellicanò GF; Madeddu G; Celesia BM; Vichi F; Menzaghi B; Bellagamba R; Orofino G; Masiello A; Molteni C; Squillace N; De Socio GV; Ricci ED; Martinelli CV; Maggi P; Falasca K; Cenderello G; Ferrara S; Di Biagio A; Bonfanti P; et alii...

Incident diabetes in course of antiretroviral therapy. in AIDS (London, England) / AIDS. 2023 Jul 1;37(8):1269-1276. doi: 10.1097/QAD.0000000000003548. Epub 2023 Mar 14.

2023
AOU Alessandria
ASL Città di Torino

Gulminetti R; Sarchi E; Cascio A; Pellicanò GF; Maggi P; Rusconi S; Celesia BM; Valsecchi L; Vichi F; Madeddu G; Martinelli CV; Socio GV; Molteni C; Orofino G; Ricci E; Menzaghi B; Squillace N; Taramasso L; Falasca K; Di Biagio A; Bonfanti P;

Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens. in BMC infectious diseases / BMC Infect Dis. 2023 Apr 14;23(1):227. doi: 10.1186/s12879-023-08191-2.

2023
AOU Alessandria
ASL Città di Torino

Falasca K; Menzaghi B; Masiello A; Saracino A; Molteni C; De Socio GV; Bargiacchi O; Madeddu G; Squillace N; Orofino G; Sarchi E; Cascio A; Celesia BM; Vichi F; Pellicanò GF; Cicalini S; Maggi P; Ricci ED; Taramasso L; Di Biagio A; Bonfanti P;

Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? in BMC infectious diseases / BMC Infect Dis. 2022 Sep 23;22(1):745. doi: 10.1186/s12879-022-07739-y.

2022
AOU Alessandria
ASL Città di Torino

Falasca K; Calza L; Parisini A; Cenderello G; Gulminetti R; Valsecchi L; Celesia BM; Martinelli CV; Pellicanò G; Sarchi E; Vichi F; Cascio A; Madeddu G; Gamboni G; Guastavigna M; Taramasso L; Molteni C; Squillace N; Menzaghi B; De Socio GV; Maggi P; Orofino G; Ricci E; Di Biagio A; Bonfanti P;

Trajectories of CD4(+)/CD8(+) T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study. in Viruses / Viruses. 2022 Oct 22;14(11):2315. doi: 10.3390/v14112315.

2022
AOU Alessandria
ASL Città di Torino

Celesia BM; Vichi F; Sarchi E; Madeddu G; Gulminetti R; Molteni C; Pellicanò GF; De Socio GV; Menzaghi B; Squillace N; Ricci E; Orofino G; Falletta A; Taramasso L; Bonfanti P; Di Biagio A;

Reversibility of Central Nervous System Adverse Events in Course of Art. in Viruses / Viruses. 2022 May 11;14(5):1028. doi: 10.3390/v14051028.

2022
AOU Alessandria
ASL Città di Torino

Grosso C; Cascio A; Angioni G; Sarchi E; Del Puente F; Conti F; Molteni C; Celesia BM; Vichi F; Madeddu G; Squillace N; De Socio GV; Menzaghi B; Ricci E; Orofino G; Taramasso L; Parruti G; Di Biagio A; Bonfanti P;

Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patients. in Brain research bulletin / Brain Res Bull. 2022 Apr;181:129-143. doi: 10.1016/j.brainresbull.2022.01.015. Epub 2022 Jan 29.

2022
ASL Città di Torino

Babiloni C; Del Percio C; Lizio R; Lopez S; Pennica A; Roma P; Correr V; Cucciolla F; Toma G; Soricelli A; Di Campli F; Aceti A; Teti E; Sarmati L; Crocetti G; Ferri R; Lorenzo I; Galli M; Negri C; Angarano G; Saracino A; Lepore L; Di Pietro M; Fusco FM; Vullo V; D'Ettorre G; Pagliano P; Di Flumeri G; Celesia BM; et alii...

Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study. in AIDS patient care and STDs / AIDS Patient Care STDS. 2021 Sep;35(9):342-353. doi: 10.1089/apc.2021.0089.

2021
AOU Alessandria
ASL Città di Torino

Dentone C; Bandera A; Cenderello G; Guadagnino G; Angioni G; Vichi F; Maggi P; Cascio A; Martinelli CV; Valsecchi L; Rusconi S; Calza L; Celesia BM; Sarchi E; Pellicanò GF; De Socio GV; Gulminetti R; Molteni C; Menzaghi B; Squillace N; Ricci ED; Orofino G; Taramasso L; De Vito A; Falasca K; Bonfanti P; Di Biagio A; Madeddu G;

Dolutegravir is not associated with weight gain in antiretroviral therapy experienced geriatric patients living with HIV. in AIDS (London, England) / AIDS. 2021 May 1;35(6):939-945. doi: 10.1097/QAD.0000000000002853.

2021
ASL Città di Torino

Guaraldi G; Calza S; Milic J; Calcagno A; Focà E; Rota M; Renzetti S; Celotti A; Siano M; Celesia BM; Piconi S; de Socio GV; Cattelan AM; Orofino G; Riva A; Nozza S; di Perri G;

Durability of Integrase STrand Inhibitor (InSTI)-based regimen in geriatric people living with HIV in the GEPPO cohort. in PloS one / PLoS One. 2021 Oct 13;16(10):e0258533. doi: 10.1371/journal.pone.0258533. eCollection 2021.

2021
ASL Città di Torino

Focà E; Calcagno A; Calza S; Renzetti S; Chiesa A; Siano M; De Socio G; Piconi S; Orofino G; Madeddu G; Cattelan AM; Nozza S; Ferrara M; Milic J; Celesia BM; Castelli F; Guaraldi G;

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort. in HIV medicine / HIV Med. 2020 Sep;21(8):523-535. doi: 10.1111/hiv.12885. Epub 2020 Jun 24.

2020
ASL Città di Torino

Taramasso L; Fabbiani M; Nozza S; De Benedetto I; Bruzzesi E; Mastrangelo A; Pinnetti C; Calcagno A; Ferrara M; Bozzi G; Focà E; Quiros-Roldan E; Ripamonti D; Campus M; Celesia BM; Torti C; Cosco L; Di Biagio A; Rusconi S; Marchetti G; Mussini C; Gulminetti R; Cingolani A; d'Ettorre G; Madeddu G; Franco A; Orofino G; Squillace N; Muscatello A; et alii...

Factors Associated With Weight Gain in People Treated With Dolutegravir. in Open forum infectious diseases / Open Forum Infect Dis. 2020 May 26;7(6):ofaa195. doi: 10.1093/ofid/ofaa195. eCollection 2020 Jun.

2020
AOU Alessandria
ASL Città di Torino

Dentone C; Vichi F; Maggi P; Bolla C; Cascio A; Valsecchi L; Martinelli CV; Conti F; Calza L; Celesia BM; Pagnucco L; Pellicanò GF; Madeddu G; De Socio GV; Menzaghi B; Squillace N; Orofino G; Ricci E; Bonfanti P; Taramasso L; Angioni G; Mastroianni A; Falasca K; Cenderello G; Di Biagio A;

Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):290-294. doi: 10.1097/QAI.0000000000002331.

2020
ASL Città di Torino

Gori A; Antinori A; Vergori A; Cossu MV; Menzaghi B; Sterrantino G; Rusconi S; Cattelan AM; Castelli F; Gianotti N; Orofino G; Ripamonti D; Savinelli S; Manzillo E; Santantonio TA; Celesia BM; Cauda R; Maserati R; d'Arminio Monforte A; Stingone C; Bonora S; Uglietti A; Termini R; Rucci F; Mancusi D;

Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort. in Infection and drug resistance / Infect Drug Resist. 2020 Jul 14;13:2291-2300. doi: 10.2147/IDR.S260449. eCollection 2020.

2020
ASL Città di Torino

Bonfanti P; De Vito A; Ricci E; Menzaghi B; Orofino G; Squillace N; Molteni C; De Socio GV; Salomoni E; Celesia BM; Dentone C; Colombo V; Madeddu G;

Impact of genotypic susceptibility score on cART outcomes during primary HIV infection. in Journal of medical virology / J Med Virol. 2019 Oct;91(10):1891-1895. doi: 10.1002/jmv.25517. Epub 2019 Jun 27.

2019
ASL Città di Torino

Giacomelli A; Fabbiani M; De Benedetto I; Nozza S; Focà E; Celesia BM; Marchetti G; Mussini C; Antinori A; d'Ettorre G; Madeddu G; Bandera A; Muscatello A; Rusconi S;

Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort. in PloS one / PLoS One. 2019 Oct 17;14(10):e0222225. doi: 10.1371/journal.pone.0222225. eCollection 2019.

2019
ASL Città di Torino

Focà E; Magro P; Guaraldi G; Riva A; Cattelan AM; De Socio GV; Costa C; Piconi S; Celesia BM; Nozza S; Orofino G; Castagna A; Di Perri G; Castelli F; Calcagno A;

Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project. in Infection and drug resistance / Infect Drug Resist. 2019 May 23;12:1385-1391. doi: 10.2147/IDR.S203813. eCollection 2019.

2019
ASL Città di Torino

Bagella P; Squillace N; Ricci E; Gulminetti R; De Socio GV; Taramasso L; Pellicanò G; Menzaghi B; Celesia BM; Dentone C; Orofino G; Bonfanti P; Madeddu G;

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data. in The Annals of pharmacotherapy / Ann Pharmacother. 2018 Aug;52(8):740-746. doi: 10.1177/1060028018761600. Epub 2018 Feb 26.

2018
ASL Città di Torino

Capetti AF; Cossu MV; Sterrantino G; Barbarini G; Di Giambenedetto S; De Socio GV; Orofino G; Di Biagio A; Celesia BM; Rusconi S; Argenteri B; Rizzardini G;

The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years. in BMC geriatrics / BMC Geriatr. 2018 Apr 20;18(1):99. doi: 10.1186/s12877-018-0789-0.

2018
ASL Città di Torino

Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G;

Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project. in Infection and drug resistance / Infect Drug Resist. 2018 Apr 26;11:615-623. doi: 10.2147/IDR.S152090. eCollection 2018.

2018
ASL Città di Torino

Bagella P; De Socio GV; Ricci E; Menzaghi B; Martinelli C; Squillace N; Maggi P; Orofino G; Calza L; Carenzi L; Celesia BM; Penco G; Di Biagio A; Valsecchi L; Vichi F; Colombo V; Parruti G; Dentone C; Falasca K; Bonfanti P; Madeddu G;

Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2879-2886. doi: 10.1093/jac/dkx169.

2017
ASL Città di Torino

Nozza S; Malagoli A; Maia L; Calcagno A; Focà E; De Socio G; Piconi S; Orofino G; Cattelan AM; Celesia BM; Gervasi E; Guaraldi G;

Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir. in AIDS (London, England) / AIDS. 2017 Jan 28;31(3):455-457. doi: 10.1097/QAD.0000000000001351.

2017
ASL Città di Torino

Bonfanti P; Madeddu G; Gulminetti R; Squillace N; Orofino G; Vitiello P; Rusconi S; Celesia BM; Maggi P; Ricci E;

Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project. in PloS one / PLoS One. 2017 Jun 20;12(6):e0179254. doi: 10.1371/journal.pone.0179254. eCollection 2017.

2017
ASL Città di Torino

Squillace N; Ricci E; Quirino T; Gori A; Bandera A; Carenzi L; De Socio GV; Orofino G; Martinelli C; Madeddu G; Rusconi S; Maggi P; Celesia BM; Cordier L; Vichi F; Calza L; Falasca K; Di Biagio A; Pellicanò GF; Bonfanti P;

PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection. in PloS one / PLoS One. 2017 Jul 20;12(7):e0181433. doi: 10.1371/journal.pone.0181433. eCollection 2017.

2017
ASL Città di Torino

Di Biagio A; Riccardi N; Signori A; Maserati R; Nozza S; Gori A; Bonora S; Borderi M; Ripamonti D; Rossi MC; Orofino G; Quirino T; Nunnari G; Celesia BM; Martini S; Sagnelli C; Mazzola G; Colletti P; Bartolozzi D; Bini T; Ladisa N; Castelnuovo F; Saracino A; Lo Caputo S;

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study. in Infection / Infection. 2016 Oct;44(5):589-97. doi: 10.1007/s15010-016-0893-z. Epub 2016 Apr 5.

2016
ASL Città di Torino

De Socio GV; Ricci E; Parruti G; Calza L; Maggi P; Celesia BM; Orofino G; Madeddu G; Martinelli C; Menzaghi B; Taramasso L; Penco G; Carenzi L; Franzetti M; Bonfanti P;

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort. in PloS one / PLoS One. 2016 Oct 14;11(10):e0164753. doi: 10.1371/journal.pone.0164753. eCollection 2016.

2016
ASL Città di Torino

Capetti AF; Sterrantino G; Cossu MV; Orofino G; Barbarini G; De Socio GV; Di Giambenedetto S; Di Biagio A; Celesia BM; Argenteri B; Rizzardini G;

Erratum to: Ageing with HIV: a multidisciplinary review. in Infection / Infection. 2015 Oct;43(5):627. doi: 10.1007/s15010-015-0808-4.

2015
ASL Città di Torino

Calcagno A; Nozza S; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G;

Ageing with HIV: a multidisciplinary review. in Infection / Infection. 2015 Oct;43(5):509-22. doi: 10.1007/s15010-015-0795-5. Epub 2015 May 19.

2015
ASL Città di Torino

Calcagno A; Nozza S; Muss C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Ripamonti D; Riva A; Di Perri G;

Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2015 Mar;45(3):289-94. doi: 10.1016/j.ijantimicag.2014.10.013. Epub 2014 No

2015
ASL Città di Torino

Madeddu G; De Socio GV; Ricci E; Quirino T; Orofino G; Carenzi L; Franzetti M; Parruti G; Martinelli C; Vichi F; Penco G; Dentone C; Celesia BM; Maggi P; Libertone R; Bagella P; Di Biagio A; Bonfanti P;

Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:233-6. doi: 10.1016/j.biopha.2014.12.006. Epub 2014 Dec 12.

2015
ASL Città di Torino

Taramasso L; Madeddu G; Ricci E; De Socio GV; Menzaghi B; Orofino G; Passerini S; Franzetti M; Maggi P; Dentone C; Martinelli C; Celesia BM; Penco G; Libertone R; Quirino T; Bonfanti P; Di Biagio A;